Home Capital Broker's Calls

CGS-CIMB keeps ‘add’ on Q&M Dental as part of managing post-Covid-19 growth expectations

Chloe Lim
Chloe Lim5/17/2022 04:54 PM GMT+08  • 3 min read
CGS-CIMB keeps ‘add’ on Q&M Dental as part of managing post-Covid-19 growth expectations
Photo: Albert Chua/The Edge Singapore
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

CGS-CIMB Research analysts Tay Wee Kuang and Kenneth Tan have kept an “add” rating on Q&M Dental with a lowered target price of 73 cents from 79 cents.

Q&M saw its revenue and core net profit grow 6.9% and 28.3% y-o-y in 1QFY2022 ended March, estimated to be driven entirely by its diagnostics business of Covid-19 testing, compared to the lower intensity of the segment a year ago.

On the other hand, revenue from its dental and medical clinics fell 1.6% y-o-y to $38.6 million despite operating 19 more dental clinics compared to a year ago.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now